Absenor

Medicinal product

(Invented) name

Absenor

Active substance (s)

Natrio valproatas

Strength

500 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

Yes

ATC code (s)

N03AG01, Valproic acid

Marketing authorisation holder

Orion Corporation, Orion Pharma, Suomija

Date of authorisation

2007-09-18

Date of renewal

2013-06-27

Documents

Valproatų vartojmo sutikimo forma_2018'09.pdf

Pacientes vadovas.pdf

0806_2 Pakuotės lapelis 191121.docx

Vadovas sveikatos prieziuros specialistams.pdf

0806_2 Absenor 500mg tab PCS PL 191121.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/1910/002

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Natrio valproatas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
20201	4788	1004788	buteliukas	N100		Receptinis	LT/1/07/0806/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-02-22	Išregistruotas
2013-06-27	Perregistruotas
2007-09-18	Registruotas